Penetrium Bioscience Inc.

Penetrium Bioscience Inc., a contract research organization provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance Quality assurance services. Founded in 2003 and based in Seoul, South Korea, Penetrium Bioscience was formerly known as Hyundai ADM Bio Inc. before rebranding in March 2026.